HCA Healthcare (NYSE:HCA) Given New $420.00 Price Target at KeyCorp

HCA Healthcare (NYSE:HCA) had its target price reduced by KeyCorp from $475.00 to $420.00 in a research note issued to investors on Monday morning, Benzinga reports. They currently have an overweight rating on the stock.

A number of other brokerages also recently issued reports on HCA. Royal Bank of Canada boosted their price objective on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research note on Friday, August 23rd. Wells Fargo & Company upped their price target on HCA Healthcare from $365.00 to $395.00 and gave the stock an “equal weight” rating in a research note on Tuesday, October 22nd. Morgan Stanley began coverage on HCA Healthcare in a research note on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 price target on the stock. UBS Group boosted their price objective on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a report on Wednesday, August 14th. Finally, Truist Financial boosted their price objective on HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, August 19th. Five investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and three have issued a strong buy rating to the stock. Based on data from MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $379.11.

HCA Healthcare Stock Down 0.7 %

Shares of NYSE:HCA opened at $358.57 on Monday. The company has a market capitalization of $92.54 billion, a price-to-earnings ratio of 16.10, a P/E/G ratio of 1.52 and a beta of 1.67. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. The business’s 50-day moving average is $393.62 and its 200-day moving average is $353.85. HCA Healthcare has a 1 year low of $223.73 and a 1 year high of $417.14.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.74%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s dividend payout ratio is currently 11.85%.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.60% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in HCA. Bangor Savings Bank increased its position in shares of HCA Healthcare by 112.5% in the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after acquiring an additional 45 shares during the period. MFA Wealth Advisors LLC purchased a new stake in HCA Healthcare in the 2nd quarter worth approximately $27,000. Unique Wealth Strategies LLC purchased a new position in shares of HCA Healthcare during the second quarter valued at approximately $28,000. GPS Wealth Strategies Group LLC lifted its stake in HCA Healthcare by 284.0% in the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after acquiring an additional 71 shares during the period. Finally, Benjamin F. Edwards & Company Inc. bought a new position in HCA Healthcare in the 2nd quarter worth $33,000. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.